Ignite Creation Date:
2025-12-25 @ 3:21 AM
Ignite Modification Date:
2026-02-27 @ 2:21 PM
Study NCT ID:
NCT03680105
Status:
COMPLETED
Last Update Posted:
2020-04-27
First Post:
2018-08-29
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Safety and Tolerability Study of RJX Drug Product in Healthy Participants
Sponsor:
Reven Pharmaceuticals, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-08-24
Start Date Type:
ACTUAL
Primary Completion Date:
2019-01-15
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-01-15
Completion Date Type:
ACTUAL
First Submit Date:
2018-08-29
First Submit QC Date:
None
Study First Post Date:
2018-09-21
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2020-03-31
Results First Submit QC Date:
None
Results First Post Date:
2020-04-14
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-04-14
Last Update Post Date:
2020-04-27
Last Update Post Date Type:
ACTUAL